Enterobacteriaceae				Acinetobacter spp.
	In patients		Out patients		In patients		Out patients
	(n=6,680)		(n=1,688)		(n=1,161)		(n=223)
	%S	MIC90	%S	MIC90	%S	MIC90	%S	MIC90
Tigecycline	96.3	1	96.3	1	98.4	1	99.1	1
Amikacin	98.9	4	99.3	4	77.9	>64	89.2	32
Cefepime	94.5	4	97.4	1	45.5	>32	66.8	>32
Ceftazidime	83.9	32	90.8	8	46.9	>32	66.4	>32
mipenem	98.6	1	99	1	83	16	93.7	2
Levofloxacin	85.6	8	88.7	4	49.4	>8	67.3	>8
Minocycline	85.1	8	95.9	8	89.5	8	91	4
PipTazo	88.3	32	89.9	8	76.1	>128	86.5	128

	S aureus				Enierococcus spp.
	In patients		Out patients		In patients		Out patients
	(n=1,919)		(n=526)		(n=1,302)		(n=221)
	%S	MIC90	%S	MIC90	%S	MIC90	%S	MIC90
Tiqecycline	100	0.25	100	0.25	98.6	0.12	97.3	0.12
Levofloxacin	56.3	32	66.9	32	44.8	>32	52	>32
Linezolid	100	4	100	2	96.6	2	96.8	2
Minocvcline	98	0.5	99.4	0.5	50.2	>8	42.5	>8
Vancomycin	100	1	100	1	81.7	>32	88.6	>32